UBS Maintains Neutral on Corpay, Raises Price Target to $465
UBS analyst Chris Zhang maintains Corpay (NYSE:CPAY) with a Neutral and raises the price target from $415 to $465.
Share
Why It Matters
An expert thinks Corpay stock might be worth more money than before. She still thinks waiting or watching is the smart move right now.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.